Bubblr (BBLR) 10-Q/A 16 Jul 24 2024 Q1 Quarterly report (amended) Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2024	May 07, 2024
Cover [Abstract]
Document Type	10-Q/A
Amendment Flag	true
Amendment Description	Bubblr, Inc (“the Company”) is filing this Amendment No. 1 to its Quarterly Report Form 10-Q for the quarterly period ended March 31, 2024 (the “Original Filing”), which was originally filed with the Securities and Exchange Commission (“SEC”) on May 7, 2024. The purpose of this filing is on May 3, 2024, the SEC entered an order instituting settled administrative and cease-and-desist proceedings against BF Borgers CPA PC (“Auditor”), the Company’s previous auditor.
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	333-260902
Entity Registrant Name	Bubblr, Inc.
Entity Central Index Key	0001873722
Entity Tax Identification Number	86-2355916
Entity Incorporation, State or Country Code	WY
Entity Address, Address Line One	21 West 46th Street
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10036
City Area Code	(646)
Local Phone Number	814 7184
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		159,690,447

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash	$ 951	$ 7,668
Other receivables	88,937	87,503
Total current assets	89,888	95,171
Non-current Assets:
Property and equipment, net	2,349	31,302
Intangible assets, net	1,409,681	1,456,628
Total non-current assets	1,412,030	1,487,930
TOTAL ASSETS	1,501,918	1,583,101
Current Liabilities:
Accounts payable	398,365	373,606
Accrued liabilities	1,106,074	943,007
Total current liabilities	1,768,409	1,487,471
Non-current liabilities:
Warrant derivative liability	40,367	39,116
Total non-current liabilities	588,708	591,755
Total Liabilities	2,357,117	2,079,226
COMMITMENTS AND CONTINGENCIES
Stockholders’ Equity (Deficit)
Series C Convertible Preferred Stock, $0.001 par value, 2,000 authorized, 903 shares issued and outstanding	1	1
Common stock, $0.01 par value, 3,000,000,000 shares authorized; 159,690,447 shares issued and outstanding	1,596,904	1,596,904
Additional paid-in capital	13,277,905	13,168,915
Accumulated deficit	(16,095,315)	(15,612,775)
Accumulated other comprehensive income	365,306	350,830
Total Stockholders’ Equity (Deficit)	(855,199)	(496,125)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	1,501,918	1,583,101
Nonrelated Party [Member]
Current Liabilities:
Loans payable		12,611
Related Party [Member]
Current Liabilities:
Loans payable	263,970	158,247
Non-current liabilities:
Loans payable to related parties, non-current	$ 548,341	$ 552,639

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023	Mar. 04, 2023
Preferred stock, par value	$ 0.001
Preferred stock, shares authorized	25,000,000
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	3,000,000,000	3,000,000,000
Common stock, shares issued	159,690,447	159,690,447
Common stock, shares outstanding	159,690,447	159,690,447
Series C Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001	$ 1,200
Preferred stock, shares authorized	2,000	2,000	2,000
Preferred stock, shares issued	903	903
Preferred stock, shares outstanding	903	903

Consolidated Statement of Opera

Consolidated Statement of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue
Sales	$ 1,504
Cost of sales	622
Gross profit	882
Operating Expenses
General and administrative	310,068	16,289
Professional fees	8,028	(225,570)
Sales and marketing	18,173	312,463
Amortization and depreciation	53,991	59,627
Research and development	47,865	39,152
Total operating expense	438,125	201,961
Operating loss	(437,243)	(201,961)
Other income (expense)
Other income	1,478	98
Interest expense	(3,592)	(1,129)
Disposal of fixed assets	(9,355)
Gain (loss) on change in fair value of warrant derivative liability	(1,251)	(72,519)
Foreign currency transaction (loss) gain	(10,904)	21,175
Total other income (expense)	(23,624)	(52,375)
Net loss before income tax	(460,867)	(254,336)
Provision for income tax
Net loss after income tax	(460,867)	(254,336)
Other comprehensive income (loss)
Foreign currency translation gain (loss)	14,476	(19,142)
Total other comprehensive income (loss)	14,476	(19,142)
Net comprehensive loss	$ (446,391)	$ (273,478)
Net loss per common share, basic	$ 0	$ 0
Net loss per common share, diluted	$ 0	$ 0
Weighted average number of common shares outstanding, basic	159,690,447	154,904,171
Weighted average number of common shares outstanding, diluted	159,690,447	154,904,171

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders' Deficit (Unaudited) - USD ($)	Preferred Stock [Member] Series C Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Series C Preferred Stock [Member]	Total
Balance at Dec. 31, 2022	$ 1	$ 1,543,093	$ 11,006,607	$ (12,875,437)	$ 412,013		$ 86,277
Balance, shares at Dec. 31, 2022	903	154,309,318
Issuance of common shares for Services - Consulting		$ 14,558	270,780				285,338
Issuance of common shares for Services - Consulting, shares		1,455,784
Forfeit of restricted stock units			(659,052)				(659,052)
Issuance of common shares for Series C Preferred Shares Dividend		$ 1,837	20,296				22,133
Issuance of common shares for series C Preferred Shares Dividend, shares		183,676
Dividend Series C Preferred Shares				(21,672)			(21,672)
Net Loss				(254,336)			(254,336)
Other comprehensive income					(19,142)		(19,142)
Balance at Mar. 31, 2023	$ 1	$ 1,559,488	10,638,631	(13,151,445)	392,871		(560,454)
Balance, shares at Mar. 31, 2023	903	155,948,778
Balance at Dec. 31, 2023	$ 1	$ 1,596,904	13,168,915	(15,612,775)	350,830		(496,125)
Balance, shares at Dec. 31, 2023	903	159,690,447
Issuance of common shares for Series C Preferred Shares Dividend						$ 43,805
Dividend Series C Preferred Shares				(21,673)			(21,673)
Net Loss				(460,867)			(460,867)
Other comprehensive income					14,476		14,476
Vesting of Share Options			108,990				108,990
Balance at Mar. 31, 2024	$ 1	$ 1,596,904	$ 13,277,905	$ (16,095,315)	$ 365,306		$ (855,199)
Balance, shares at Mar. 31, 2024	903	159,690,447

Consolidated Statement of Cashf

Consolidated Statement of Cashflows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows from Operating Activities:
Net loss	$ (460,867)	$ (254,336)
Net loss to net cash used in operating activities:
Stock-based compensation		285,338
Forfeit of restricted stock units		(659,052)
Vesting of stock-based compensation	108,990
Change in fair value of warrant derivative liability	1,251	72,519
Disposal of fixed assets	9,355
Amortization of intangible asset	51,489	56,521
Depreciation	2,502	3,106
Changes in operating assets and liabilities:
(Increase) decrease in other receivables	(2,121)	3,778
Increase in accounts payable	25,674	336,901
Increase in accrued liabilities	145,563	(3,156)
Net cash used in operating activities	(118,164)	(158,381)
Cash flows from investing activities
Purchase of intangible assets	(15,566)	(11,138)
Proceeds on the sale of fixed assets	16,960
Net cash used in investing activities	1,394	(11,138)
Cash flows from financing activities
Repayment of loans payable	(12,611)	(2,430)
Repayment of loans payable - related party		(18,228)
Proceeds from loans payable - related party	105,076	223,777
Net cash provided by financing activities	92,465	203,119
Effects of exchange rate changes on cash	17,588	(31,018)
Net Change in Cash	(6,717)	2,582
Cash - Beginning of Period	7,668	32,533
Cash - End of Period	951	35,115
Supplemental information:
Cash paid for interest	301	4,774
Cash paid for taxes

ORGANIZATION, BUSINESS AND LIQU

ORGANIZATION, BUSINESS AND LIQUIDITY	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
ORGANIZATION, BUSINESS AND LIQUIDITY	NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY Organization and Operations On March 26, 2020, Bubblr Holdings Ltd. (a UK company formed on February 18, 2016) merged into U.S. Wireless Online, Inc. (“UWRL”), a Wyoming corporation formed on October 22, 2019 100 Bubblr, Inc. is an application software company that is currently developing its disruptive Ethical Web platform. This WEB.Ɛ platform will provide a holistic view of progress in developing digital products, services, and teams — designed to inform our ability to use our in-house code and that of our partners, lead advances in development criteria, and respond quickly to shifts in trends and applications. Going Concern Matters The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”), which contemplates the Company’s continuation as a going concern. The Company incurred a net comprehensive loss of $ 446,391 16,095,315 1,678,521 Management intends to raise additional operating funds through equity and/or debt offerings. However, there can be no assurance management will be successful in its endeavors. There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placement, public offerings, and/or bank financing necessary to support its working capital requirements. To the extent that funds generated from operations and any private placements, public offerings, and/or bank financing are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available to the Company, it may be required to curtail or cease its operations. Due to uncertainties related to these matters, there exists substantial doubt about the ability of the Company to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern. Unaudited Interim Financial Statements The accompanying interim unaudited condensed consolidated financial statements (“Interim Financial Statements”) of the Company and its 100%-owned subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and are presented in accordance with the requirements of Form 10-Q and Regulation S-X. Accordingly, these Interim Financial Statements do not include all of the information and notes required by GAAP for complete financial statements. These Interim Financial Statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2023 included in the Company’s Form 10-K. In the opinion of management, the Interim Financial Statements included herein contain all adjustments, including normal recurring adjustments, considered necessary to present fairly the Company’s financial position, the results of operations and cash flows for the periods presented. The operating results and cash flows of the interim periods presented herein are not necessarily indicative of the results to be expected for any other interim period or the full year.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated interim financial statements have been prepared in accordance with GAAP. The Company’s fiscal year-end is December 31. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries: Bubblr Holdings Ltd., Bubblr Ltd., and Bubblr CLN Ltd. All significant inter-company balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. Intangible Assets - Capitalized Product Development Costs Accounting Standards Codification (“ASC”) Topic 350, “Intangibles - Goodwill and Other” includes software that is part of a product or process to be sold to a customer and shall be accounted for under Subtopic 985-20. Our products contain embedded software internally developed by Bubblr, which is an integral part of these products because it allows the various components of the products to communicate with each other and the products are clearly unable to function without this coding. The costs of product development that are capitalized once technological feasibility is determined (noted as Technology in progress in the Intangible Assets table, in Note 5 to Notes to Unaudited Consolidated Financial Statements) include sub-contractor expenses, payroll, employee benefits, and other headcount-related expenses associated with product development. The Company determines that technological feasibility for products is reached after all high-risk development issues have been resolved. Once the products are available for general release to the Company’s customers, the Company ceases capitalizing the product development costs and any additional costs, if any, are expensed. The capitalized product development costs are amortized on a product-by-product basis using the straight-line amortization. The amortization begins when the products are available for general release to our customers. Segment Reporting Accounting Standards Codification (“ASC”) 280, “Segment Reporting,” requires public companies to report financial and descriptive information about their reportable operating segments. The Company identifies operating segments based on how our chief operating decision maker internally evaluates separate financial information, business activities and management responsibility. Accordingly, the Company has one reportable segment, consisting of fees for App usage. SCHEDULE OF SEGMENT REPORTING Three Months Ended March 31, Net sales: 2024 2023 North America $ 1,504 $ - Europe - - Totals $ 1,504 $ - Net sales $ 1,504 $ - Long-lived assets, net (property and equipment and intangible assets): March 31, 2024 June 30, 2023 North America $ - $ - Europe 2,349 31,302 Totals $ 2,349 $ 31,302 Long-lived assets, net $ 2,349 $ 31,302 Intangible Assets The cost of intangible assets with determinable useful lives is amortized to reflect the pattern of economic benefits consumed on a straight-line basis over the estimated periods benefited. Patents, technology, and other intangibles with contractual terms are generally amortized over their respective legal or contractual lives. When certain events or changes in operating conditions occur, an impairment assessment is performed, and lives of intangible assets with determinable lives may be adjusted. Long-Lived Assets Long-lived assets are evaluated for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate. Each impairment test is based on comparing the undiscounted future cash flows to the recorded value of the asset. The asset is written down to its estimated fair value if an impairment is indicated. The Company did no 6,367 Convertible Financial Instruments The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP. Fair Value of Financial Instruments The Company accounts for financial instruments in accordance with ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below: Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 – Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data. Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. The carrying value of the Company’s current assets and liabilities are deemed to be their fair value due to the short-term maturity and realization. During the year ended December 31, 2022, the Company acquired warrant derivative liabilities, which are Level 3 financial instruments adjusted to fair market value on reporting dates. At March 31, 2024 and December 31, 2023 the warrant liabilities balances were $ 40,367 39,116 Stock Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Compensation–Stock Compensation,” which prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Share-based payments to employees and non-employees, including grants of stock options, are recognized as compensation expenses in the financial statements based on the fair values of the stock awards on the grant date. That expense is recognized over the period required to provide services in exchange for the award, known as the requisite service period (usually the vesting period ). Common Stock Purchase Warrants and Derivative Financial Instruments Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses the classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required. Basic and Diluted Net Loss per Common Share Pursuant to ASC 260, “Earnings Per Share,” basic net income and net loss per share are computed by dividing the net income and net loss by the weighted average number of common shares outstanding. Diluted net income and net loss per share is the same as basic net income and net loss per share when their inclusion would have an anti-dilutive effect due to our continuing net losses. The following outstanding stock was excluded from the computation of diluted net loss per share as the result was anti-dilutive. SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE 2024 2023 March 31, 2024 2023 (Shares) (Shares) Series C Preferred Stock 3,384,135 3,384,135 Warrants 2,358,101 2,358,101 Total 5,742,236 5,742,236 Anti-dilutive shares 5,742,236 5,742,236 Foreign Currency Translations The functional currency of the Company’s international subsidiaries is generally their local currency of Great British Pounds (GBP). Local currency assets and liabilities are translated at the exchange rates on the balance sheet date, and local currency revenues and expenses are translated at weighted average exchange rates during the period. Equity accounts are translated at historical rates. The resulting translation adjustments are recorded directly into accumulated other comprehensive income. SCHEDULE OF FOREIGN CURRENCY TRANSLATION ADJUSTMENTS 2024 2023 2023 March 31, December 31, 2024 2023 2023 Period-end GBP£: U.S.$ exchange rate 1.2632 1.2341 1.2731 Weighted average GBP£: U.S.$ exchange rate 1.2684 1.2152 1.2441 Aggregate transaction gains or losses, including gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of certain inter-company balances, are included in the statement of operations as other income and expense. Gains on foreign exchange transactions totaling $ 5,210 19,142 Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes.” The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount believed more likely than not to be realized. As of March 31, 2024, and December 31, 2023, the Company did not have any amounts recorded pertaining to uncertain tax positions. UK Taxes We do not consider ourselves to be engaged in a trade or business in the UK and, as such, do not expect to be subject to UK corporate income taxation. We have subsidiaries based in the UK that are subject to the tax laws of that country. Under current law, those subsidiaries are taxed at the applicable corporate income tax rates. Should any UK subsidiaries be deemed to undertake business activities in the US, they would be subject to US corporate income tax in respect of their US activities only. Relief would then be available against the UK tax liabilities in respect of the overseas taxes arising from US activities. At present, this is not applicable as our UK subsidiaries only undertake activities in the UK. Our UK subsidiaries file separate UK income tax returns. UK Tax Risk Companies that are incorporated outside the UK may become subject to UK taxes in a number of circumstances, including circumstances in which (1) they are deemed resident in the UK for tax purposes by reason of their central management and control being exercised from the UK or (2) they are treated as carrying on a trade, investing or carrying on any other business activity in the UK, whether or not through a UK Permanent Establishment (“PE”). In addition, the Finance Act 2015 introduced a new tax known as the diverted profits tax (“DPT”), which is charged at 25% of any “taxable diverted profit.”. The DPT has had an effect since April 1, 2015, and may apply in circumstances including (1) where arrangements are designed to ensure that a non-UK resident company does not carry on a trade in the UK through a PE; and (2) where a tax reduction is obtained through the involvement of entities or transactions lacking economic substance. We intend to operate in such a manner that none of our companies should be subject to the UK DPT and that none of our companies (other than those companies incorporated in the UK) should: (1) be treated as resident in the UK for tax purposes; (2) carry on a trade, invest or carry on any other business activity in the UK (whether or not through a UK PE). However, this result is based on certain legal and factual determinations, and since the scope and the basis upon which the DPT will be applied by HM Revenue & Customs (“HMRC”) in the UK remains uncertain and since applicable law and regulations do not conclusively define the activities that constitute conducting a trade, investment or business activity in the UK (whether or not through a UK PE), and since we cannot exclude the possibility that there will be a change in law that adversely affects the analysis, HMRC might successfully assert a contrary position. The terms of an income tax treaty between the UK and the home country of the relevant Bubblr subsidiary, if any, could contain additional protections against UK tax. Any arrangements between UK-resident entities of Bubblr and other entities of Bubblr are subject to the UK transfer pricing regime. Consequently, if any agreement between a UK resident entity of Bubblr and any other Bubblr entity (whether that entity is resident in or outside of the UK) is found not to be on arm’s length terms and, as a result, a UK tax advantage is being obtained, an adjustment will be required to compute UK taxable profits as if such an agreement were on arm’s length terms. Any transfer pricing adjustment could adversely impact the tax charge incurred by the relevant UK resident entities of Bubblr. Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial statements. Reclassifications Certain accounts have been reclassified in prior periods to conform to current period presentation. Compensation expense that was previously reported separately has been combined with general and administrative expenses in the Consolidated Statements of Operations and Comprehensive Loss for all periods presented.

OTHER RECEIVABLES

OTHER RECEIVABLES	3 Months Ended
	Mar. 31, 2024
Credit Loss [Abstract]
OTHER RECEIVABLES	NOTE 3 – OTHER RECEIVABLES Other receivables consisted of the following: SCHEDULE OF OTHER RECEIVABLES March 31, December 31, 2024 2023 Deposit $ 200 $ 200 UK R&D credit 79,582 80,205 UK VAT receivable 9,155 7,098 Total other receivables $ 88,937 $ 87,503

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	3 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	NOTE 4 - PROPERTY AND EQUIPMENT Property and equipment consisted of the following: SCHEDULE OF PROPERTY PLANT AND EQUIPMENT Motor Vehicles Computer Equipment Office Equipment Total Cost At December 31, 2023 $ 53,470 $ 29,646 $ - $ 83,116 Additions - - - - Disposals (53,054 ) (3,502 ) - (56,556 ) Effects of currency translation (416 ) (231 ) - (647 ) At March 31, 2024 - 25,913 - 25,913 Less accumulated depreciation At December 31, 2023 $ 25,997 $ 25,817 $ - $ 51,814 Depreciation expense 1,053 1,449 - 2,502 Disposals (26,847 ) (3,502 ) - (30,349 ) Effects of currency translation (203 ) (200 ) - (403 ) At March 31, 2024 - 23,564 - 23,564 Net book value At March 31, 2024 - 2,349 - 2,349 At December 31, 2023 $ 27,473 $ 3,829 $ - $ 31,302 Depreciation expense was $ 2,502 3,106 9,317 on the disposal of a motor vehicle for the three months ended March 31, 2024.

INTANGIBLE ASSETS

INTANGIBLE ASSETS	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS	NOTE 5 - INTANGIBLE ASSETS The Company has the following intangible assets: Intangible assets consisted of the following: SCHEDULE OF INTANGIBLE ASSETS Patents Trademarks Intellectual Property Capitalized Acquisition Costs Total Cost: At December 31, 2023 $ 220,926 $ 36,558 $ 3,109,540 $ 45,745 $ 3,412,769 Cost, beginning balance $ 220,926 $ 36,558 $ 3,109,540 $ 45,745 $ 3,412,769 Additions 15,139 427 - - 15,566 Effects of currency translation (1,718 ) (285 ) (24,180 ) - (26,183 ) At March 31, 2024 $ 234,347 $ 36,700 $ 3,085,360 $ 45,745 $ 3,402,152 Cost, ending balance $ 234,347 $ 36,700 $ 3,085,360 $ 45,745 $ 3,402,152 Less accumulated amortization: At December 31, 2023 $ 8,541 $ - $ 1,940,736 $ 6,864 $ 1,956,141 Accumulated amortization, beginning balance $ 8,541 $ - $ 1,940,736 $ 6,864 $ 1,956,141 Amortization expense 1,630 - 49,287 572 51,489 Effects of currency translation (70 ) - (15,089 ) - (15,159 ) At March 31, 2024 $ 10,101 $ - $ 1,974,934 $ 7,436 1,992,471 Accumulated amortization, ending balance $ 10,101 $ - $ 1,974,934 $ 7,436 1,992,471 Net book value At March 31, 2024 $ 224,246 $ 36,700 $ 1,110,426 $ 38,309 $ 1,409,681 At December 31, 2023 $ 212,385 $ 36,558 $ 1,168,804 $ 38,881 $ 1,456,628 Net book value $ 212,385 $ 36,558 $ 1,168,804 $ 38,881 $ 1,456,628 ● Patents A Patent on the Internet-Search Mechanism (“IBSM”) has been granted in the United States, South Africa, New Zealand, Canada, and Australia. The patent is pending in the European Union, and the United Kingdom. Patents on Contextual Enveloping of Dynamic Hypertext Links and Real-Time Data Processing are pending in the United States Patents are reported at cost, less accumulated amortization, and accumulated impairment loss. Costs include expenditure that is directly attributable to the acquisition of the asset. Once a patent provides economic benefit to the Company, amortization is provided on a straight-line basis on all patents over their expected useful lives of 20 ● Intellectual Property Intellectual Property capitalizes the Company’s qualifying internal research and developments costs . 7 ● Trademarks The Company has the following trademarks. Mark Category Proprietor Country Class(es) Status Reg. Date. File No. CITIZENS JOURNALIST Words Bubblr Limited European Union 9 38 REGISTERED 16-Nov-2019 206382.EM.01 CITIZENS JOURNALIST Word Bubblr Limited United Kingdom 9 38 REGISTERED 05-Jul-2019 206382.GB.01 CITIZENS JOURNALIST Words Bubblr Limited United Kingdom 9 38 REGISTERED 16-Nov-2019 206382.GB.02 CITIZENS JOURNALIST Word Bubblr Limited United States 9 38 41 42 REGD-DEC USE 08-Feb-2022 206382.US.01 Words and Color Device Bubblr Limited European Union 9 38 REGISTERED 16-Nov-2019 206383.EM.01 Series of Logos Bubblr Limited United Kingdom 9 38 REGISTERED 05-Jul-2019 206383.GB.01 Words and Color Device Bubblr Limited United Kingdom 9 38 REGISTERED 16-Nov-2019 206383.GB.02 Words and Device Bubblr Limited United States 9 38 41 42 ACCEPTED 206383.US.01 BAU NOT OK/BAU Not OK Series of Marks Bubblr Limited United Kingdom 9 38 REGISTERED 11-Oct-2019 208674.GB.01 NEWZMINE/NewzMine Series of Marks Bubblr Limited United Kingdom 9 38 42 REGISTERED 25-Dec-2020 227753.GB.01 The Company capitalizes trademark costs where the likelihood of acceptance is expected. Each trademark has been determined to have an infinite useful life and is assessed each reporting period for impairment. If there has been a reduction in the value of the trademark or if the trademark is not successfully registered, the assets will be impaired and charged to expense in the period of impairment. Amortization expense was $ 51,489 56,521

ACCRUED LIABILITIES

ACCRUED LIABILITIES	3 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
ACCRUED LIABILITIES	NOTE 6 – ACCRUED LIABILITIES Accrued liabilities consisted of the following: SCHEDULE OF ACCRUED LIABILITIES March 31, December 31, 2024 2023 Director fees $ 120,000 $ 90,000 Dividends payable 86,688 65,016 Other accruals 49,892 76,945 Settlement payable 166,986 166,986 Wages and salaries 682,508 544,060 Total Accrued liabilities $ 1,106,074 $ 943,007

LOANS PAYABLE TO RELATED PARTIE

LOANS PAYABLE TO RELATED PARTIES	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
LOANS PAYABLE TO RELATED PARTIES	NOTE 7 – LOANS PAYABLE TO RELATED PARTIES The Company had the following loans payable to related parties: SCHEDULE OF LOANS PAYABLE TO RELATED PARTIES March 31, December 31, 2024 2023 Loan 1 (May 23, 2022) – Loan payable to Stephen Morris $ 229,575 $ 125,910 Loan 2 (September 7, 2022) – Loan payable to Stephen Morris 548,341 552,639 September 8, 2022 – Loan payable to Director 34,395 32,337 Total loan payable to related parties 812,311 710,886 Less – current portion 263,970 158,247 Total – noncurrent $ 548,341 $ 552,639 ● Loan 1 (May 23, 2022) - Stephen Morris, Founder, CTO and Chair. On May 23, 2022, the Company entered an amendment to the Loan Agreement between Bubblr Limited and Mr. Morris to change the loan from a demand loan to have a maturity date on the earlier of (i) the completion of an offering by Bubblr, Inc., in the amount of no less than $7,500,000 in a public offering, or (ii) two years from the date of the amendment. In addition, on a date no later than five (5) business days from the completion of bridge financing of no less than $1.5 million USD, the Company shall pay to Mr. Morris an amount equal to £115,000 GBP as an installment payment on the principal of the Loan, and the balance of the principal of the Loan shall be paid at the Maturity Date On September 6, 2022, the Company entered into a second amendment (the “Amendment”) with Bubblr Limited and Mr. Morris to add $ 60,000 52,088 On December 20, 2022, the Company entered into a third amendment (the “Amendment”) with Bubblr Limited and Mr. Morris to reduce the outstanding principal amount of the loan by $ 71,540 59,543 71,540 59,543 On December 27, 2023, Stephen Morris converted $ 821,431.87 2,489,186 0.33 ● Loan 2 (September 7, 2022) - Stephen Morris, Founder, CTO and Chair. On September 7, 2022, our wholly owned subsidiary, Bubblr Limited, entered into a new loan agreement (the “Loan Agreement”) with Mr. Morris for $ 501,049 434,060 no ● Related Party Loan – Professor Paul Morrissey, Director. On September 8, 2022, the Company entered into a new loan agreement (the “Loan Agreement”) with Professor Paul Morrissey for $ 32,337 25,401 6,954 5,700 2.85% 34,395 27,229 32,337 25,401 Total interest expense was $ 1,750 0

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 8 - RELATED PARTY TRANSACTIONS The Company had the following related party transactions: ● Loan payable to Stephen Morris ● Loan payable to Director of the Company. Loans payable to related party transactions are disclosed in Note 7.

WARRANT LIABILITY

WARRANT LIABILITY	3 Months Ended
	Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
WARRANT LIABILITY	NOTE 9 - WARRANT LIABILITY The Company analyzed the warrants issued in connection with the Series C Convertible Preferred Stock (see Note 10) for derivative accounting consideration under ASC 815, Derivatives and Hedging, and determined that the instruments should be classified as a liability due to reset provisions and variability in exercise price resulting in there being no fixed value or explicit limit to the number of shares to be delivered upon exercise. ASC 815 requires us to assess the fair market value of the derivative liability at the end of each reporting period and recognize any change in the fair market value as other income or expense item. The Company determined our warrant liabilities to be a Level 3 fair value measurement during the year based on management’s estimate of the expected future cash flows required to settle the liabilities and used the Black Scholes pricing model to calculate the fair value as of March 31, 2024. The Black Scholes model requires three basic data inputs: the exercise or strike price, time to expiration, the risk-free interest rate, the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could produce a significantly higher or lower fair value measurement. The fair value of each warrant is estimated using the Black-Scholes valuation model. For the period ended March 31, 2024, the estimated fair values of the warrant liabilities measured on a recurring basis are as follows : SCHEDULE OF ESTIMATED FAIR VALUES OF WARRANT LIABILITIES MEASURED ON A RECURRING BASIS Three Months Ended March 31, 2024 Expected term 1.59 2.50 Expected average volatility 177 220 % Expected dividend yield 8.33 % Risk-free interest rate 1.50 5.46 % The following table summarizes the changes in the warrant liabilities during the three months ended March 31, 2024, and year ended December 31, 2023: SUMMARY OF CHANGES IN WARRANT LIABILITIES Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Warrant liability December 31, 2022 $ 198,479 Addition of new warrants - Change in fair value of warrant liability (159,363 ) Warrant liability as of December 31, 2023 $ 39,116 Addition of new warrants $ - Change in fair value of warrant liability 1,251 Warrant liability as of March 31, 2024 $ 40,367

STOCKHOLDERS_ EQUITY

STOCKHOLDERS’ EQUITY	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 10 - STOCKHOLDERS’ EQUITY Preferred Stock The Company has authorized 25,000,000 0.001 Series C Convertible Preferred Stock On March 4, 2023, the Company filed a Certificate of Designation with the Wyoming Secretary of State, which established 2,000 1,200 The Company has the right to redeem the Series C Convertible Preferred Stock in accordance with the following schedule: ● The Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days of written notice at a price equal to 120% of the Stated Value together with any accrued but unpaid dividends; and ● The Company shall pay an 8 The Series C Convertible Preferred Stock will vote together with the common stock on an as-converted basis subject to the Beneficial Ownership Limitations (as set forth in the Certificate of Designation). Each share of the Series C Convertible Preferred Stock is convertible, at any time and from time to time from and after the issuance at the option of the Holder thereof, into that number of shares of Common Stock (subject to Beneficial Ownership Limitations) determined by dividing the Stated Value of $ 1,200 0.3202 On March 4, 2022, the Company entered into a Securities Purchase Agreement (the “GHS Securities Purchase Agreement”) with GHS Investments, LLC (“GHS”), whereby GHS agreed to purchase, in tranches, up to $ 700,000 700 On March 4, 2022, the Company issued to GHS the first tranche of 300 35 941,599 75 GHS delivered gross proceeds of $ 266,000 On March 9, 2022, the Company entered a Securities Purchase Agreement with Proactive Capital Partners LP (“Proactive”), whereby Proactive agreed to purchase 160 The Company agreed to issue Proactive commitment shares of 8 472,205 75 On March 9, 2022, the Company issued 168 290,000 On April 24, 2022, the Company issued the second tranche of 200 562,149 184,000 On May 25, 2022, the Company issued the third tranche of 100 92,000 On September 24, 2022, the Company issued the fourth tranche of 100 281,074 92,000 On September 7, 2022, our wholly owned subsidiary, Bubblr Limited, entered into a new loan agreement (the “Loan Agreement”) with Mr. Morris for £ 434,060 550,468 200,000 345,220 281,000 64,220 71,703 As a result of the above transactions, the Company received total net proceeds of $ 789,000 721,275 28,043 95,768 As of March 31, 2024 and December 31, 2023, the Company had 903 Common Stock The Company has authorized 3,000,000,000 0.01 During the three months ended March 31, 2023, the Company issued the following unregistered securities: ● 625,000 100,000 ● 500,000 65,000 ● 311,159 43,805 ● 1,455,784 285,338 During the three months ended March 31, 2024, the Company did not issue unregistered securities. As of March 31, 2024, and December 31, 2023, the Company had 159,690,447 The above securities were issued in reliance on the exemption from registration provided by Section 4.(a)(2) of the Securities Act of 1933, as amended, and/or in reliance on the exception from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended. Warrants The Company identified conversion features embedded within warrants issued during the three months ended March 31, 2023. The Company has determined that the conversion feature of the Warrants represents an embedded derivative since the conversion price includes a reset provision which could cause adjustments in redemption value and the number of shares issued upon exercise (see Note 9 - Warrant Liability). A summary of activity during the three-month period ended March 31, 2024, follows: SUMMARY OF WARRANTS ACTIVITY Warrants Outstanding Weighted Average Number of Weighted Average Remaining life Warrants Exercise Price (years) Outstanding, December 31, 2023 2,538,101 $ 0.32 4.27 Granted - - - Exercised - - - Forfeited/canceled - - - Outstanding, March 31, 2024 2,538,101 $ 0.32 3.52 Exercisable Warrants, March 31, 2024 2,538,101 $ 0.32 3.52 The following table summarizes information relating to outstanding and exercisable warrants as of March 31, 2024: SUMMARY OF INFORMATION RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS Warrants Outstanding Warrants Exercisable Number of Weighted Average Remaining Contractual life (in years) Weighted Average Number of Shares Weighted Average 941,599 3.43 $ 0.34 941,599 $ 0.34 472,205 3.44 0.34 472,205 0.34 562,149 3.57 0.35 562,149 0.35 281,074 3.65 0.22 281,074 0.22 281,074 3.74 0.22 281,074 0.22 2,538,101 3.52 $ 0.32 2,538,101 $ 0.32 As of March 31, 2024, the intrinsic value of the warrants is $ 0 2022 Equity Incentive Plan On April 1, 2023, the Company granted options for purchasing our Common stock to executives, management, and a non-executive director as consideration for time served. The Board of Directors determine the terms of the stock option grants that are consistent with our 2022 Equity Incentive Plan. Our stock option grant general policy is that options vest 40% after 90 days of service, and the remaining options vest monthly over two years. The maximum term is ten years. The following table summarizes the stock options activity for the three months ended March 31, 2024: SUMMARY OF STOCK OPTION ACTIVITY Number of Shares Weighted-Average Exercise Price (per share) Outstanding as of December 31, 2023 14,400,000 $ 0.1560 Granted - - Exercised - - Forfeited or expired - - Outstanding at March 31, 2023 14,400,000 $ 0.1560 Exercisable at March 31, 2024 10,788,000 Weighted-average fair value of options granted in the period $ 0.1560 The total intrinsic value of options on March 31, 2023, is zero because the closing stock price was below the weighted average exercise value. The weighted average fair value of stock options granted is based on the Black-Scholes option pricing model using the following weighted average assumptions. SCHEDULE OF THE WEIGHTED AVERAGE FAIR VALUE OF STOCK OPTIONS Three Month March 31, 2024 Expected life in years 9.01 Risk-free interest rate 4.20 % Annual forfeiture rate 0 % Volatility 221 % Expected dividend yield 0 % The following table summarizes certain information regarding the Company’s non-vested shares as of the three-month period ended March 31, 2024: SCHEDULE OF NON-VESTED SHARES Number of Shares Weighted-Average Non-vested as of December 31, 2023 14,400,000 $ 0.1560 Granted - - Forfeited or expired - - Vested (10,788,000 ) 0.1560 Non-vested as of March 31, 2024 3,612,000 $ 0.1560 The following table summarizes the stock options exercisable for the three-month period ended March 31, 2024: SUMMARY OF STOCK OPTION ACTIVITY OUTSTANDING AND EXERCISABLE Options Options Outstanding Exercisable Number of shares 14,400,000 10,788,000 Weighted-average contractual life in years 9.01 9.01 Weighted-average exercise price $ 0.1560 $ 0.1614 Intrinsic value $ 0.00 $ 0.00 As of March 31, 2024, the Company recognized $ 108,990 517,783

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 11 - COMMITMENTS AND CONTINGENCIES Lease The Company rents virtual space month-to-month at 21 West 46th St, New York, NY 10036 . 200 his lease is exempt from ASC 842 lease accounting due to its short term. Investor Relations On February 14, 2023, the Company entered a Consulting Agreement with Beyond Media SEZC. The agreement is for twelve months. Beyond Media will receive $ 7,000 1,000,000 180,000 On June 15, 2023, the Company entered a Consulting Agreement with Launchpad LLC. The agreement is for six months. Launchpad LLC will receive $ 3,000 Employment and Separation Agreements ● Steven Saunders, Former Chief Commercial Officer, and Director On January 31, 2023, the Company entered Separation Agreements with Steven Saunders. He is no longer an officer or director of our Company, and all prior agreements are terminated. To satisfy all amounts due, Mr. Saunders and the Company agreed to a settlement totaling $ 116,000 79,250 ● Rik Willard, Former Chief Executive Officer, and Director On January 31, 2023, the Company entered into Separation Agreements with Rik Willard, our then-Chief Executive Officer. Mr. Willard is no longer an officer or director of our Company, and all prior agreements are terminated in their entirety. To satisfy all amounts due, Mr. Willard and the Company agreed to a settlement total sum of $ 112,418 86,811 ● Stephen Morris, Founder, Chief Technical Officer, and Director On April 1, 2023, the Company entered into an Amended Employment Agreement with Stephen Morris, Founder, Chief Technical Officer, and Chair. The Company will compensate Mr. Morris with $ 450,000 60 180,000 5,000,000 On April 1, 2023, the Company agreed to grant Mr. Morris an option to purchase 3,360,000 shares of common stock at $0.187 per share (628,320) under the 2022 Incentive Plan Mr. Morris completed two years and three months of service. On December 31, 2023, the Company entered into a Second Amended Employment Agreement with Stephen Morris to reduce his base pay from $ 450,000 90,000 270,000 ● David Chetwood, Chief Financial Officer, and Director On April 1, 2023, the Company entered into an Amended Employment Agreement, effective February 10, 2023, with David Chetwood, Chief Financial Officer, and Director. The Company will compensate Mr. Chetwood with a base pay of $ 450,000 60 180,000 5,000,000 On May 12, 2023, the Company agreed to grant Mr. Chetwood an option to purchase 3,360,000 shares of common stock at $0.1625 per share ($546,000), with 40% vesting after 90 days of service and 60% vesting monthly over the following two years 1,092,000 On December 31, 2023, the Company entered into a Second Amended Employment Agreement with David Chetwood to reduce his base pay from $ 450,000 180,000 236,200 ● Timothy Burks, Chief Executive Officer, and Director On April 1, 2023, the Company entered into an employment agreement with Timothy Burks, Chief Executive Officer, and Director. The Company will compensate Mr. Burks $600,000 per annum base pay with payments reduced by 60% to $240,000 per annum until the Company has secured $5,000,000 in debt or equity financing. On July 1, 2023, the Company agreed to grant Mr. Burks an option to purchase 4,800,000 shares of common stock at $0.1353 per share ($649,440), with 40% vesting after 90 days of service and 60% vesting monthly over the following two years , under the 2022 Incentive Plan. As of March 31, 2024, there were 1,800,000 non-vested share options, which we will recognize over the next 15 months. On December 31, 2023, the Company entered into an Amended Employment Agreement with Timothy Burks to reduce his base pay from $ 600,000 240,000 270,000 ● Paul Morrissey, Director On April 6, 2023, the Company entered into a Non-executive Director Agreement with Paul Morrissey. The Company will compensate Mr. Morrissey $300,000 per annum directors fee, with payments reduced by 60% to $120,000 per annum until the Company has secured $5,000,000 in debt or equity financing. On July 6, 2023, the Company agreed to grant Mr. Morrissey an option to purchase 1,920,000 shares of common stock at $0.1353 per share ($259,776), with 40% vesting after 90 days of service and 60% vesting monthly over the following two years 720,000 On December 31, 2023, the Company entered into an Amended Non-Executive Director Agreement with Morrissey to reduce his director fee from $ 300,000 120,000 270,000

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 12 - SUBSEQUENT EVENTS The Company has evaluated subsequent events through May 7, 2024 when the financial statements were available to be issued. The Company has concluded no subsequent events have occurred that require disclosure.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated interim financial statements have been prepared in accordance with GAAP. The Company’s fiscal year-end is December 31.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries: Bubblr Holdings Ltd., Bubblr Ltd., and Bubblr CLN Ltd. All significant inter-company balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.
Intangible Assets - Capitalized Product Development Costs	Intangible Assets - Capitalized Product Development Costs Accounting Standards Codification (“ASC”) Topic 350, “Intangibles - Goodwill and Other” includes software that is part of a product or process to be sold to a customer and shall be accounted for under Subtopic 985-20. Our products contain embedded software internally developed by Bubblr, which is an integral part of these products because it allows the various components of the products to communicate with each other and the products are clearly unable to function without this coding. The costs of product development that are capitalized once technological feasibility is determined (noted as Technology in progress in the Intangible Assets table, in Note 5 to Notes to Unaudited Consolidated Financial Statements) include sub-contractor expenses, payroll, employee benefits, and other headcount-related expenses associated with product development. The Company determines that technological feasibility for products is reached after all high-risk development issues have been resolved. Once the products are available for general release to the Company’s customers, the Company ceases capitalizing the product development costs and any additional costs, if any, are expensed. The capitalized product development costs are amortized on a product-by-product basis using the straight-line amortization. The amortization begins when the products are available for general release to our customers.
Segment Reporting	Segment Reporting Accounting Standards Codification (“ASC”) 280, “Segment Reporting,” requires public companies to report financial and descriptive information about their reportable operating segments. The Company identifies operating segments based on how our chief operating decision maker internally evaluates separate financial information, business activities and management responsibility. Accordingly, the Company has one reportable segment, consisting of fees for App usage. SCHEDULE OF SEGMENT REPORTING Three Months Ended March 31, Net sales: 2024 2023 North America $ 1,504 $ - Europe - - Totals $ 1,504 $ - Net sales $ 1,504 $ - Long-lived assets, net (property and equipment and intangible assets): March 31, 2024 June 30, 2023 North America $ - $ - Europe 2,349 31,302 Totals $ 2,349 $ 31,302 Long-lived assets, net $ 2,349 $ 31,302
Intangible Assets	Intangible Assets The cost of intangible assets with determinable useful lives is amortized to reflect the pattern of economic benefits consumed on a straight-line basis over the estimated periods benefited. Patents, technology, and other intangibles with contractual terms are generally amortized over their respective legal or contractual lives. When certain events or changes in operating conditions occur, an impairment assessment is performed, and lives of intangible assets with determinable lives may be adjusted.
Long-Lived Assets	Long-Lived Assets Long-lived assets are evaluated for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate. Each impairment test is based on comparing the undiscounted future cash flows to the recorded value of the asset. The asset is written down to its estimated fair value if an impairment is indicated. The Company did no 6,367
Convertible Financial Instruments	Convertible Financial Instruments The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company accounts for financial instruments in accordance with ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below: Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 – Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data. Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. The carrying value of the Company’s current assets and liabilities are deemed to be their fair value due to the short-term maturity and realization. During the year ended December 31, 2022, the Company acquired warrant derivative liabilities, which are Level 3 financial instruments adjusted to fair market value on reporting dates. At March 31, 2024 and December 31, 2023 the warrant liabilities balances were $ 40,367 39,116
Stock Based Compensation	Stock Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Compensation–Stock Compensation,” which prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Share-based payments to employees and non-employees, including grants of stock options, are recognized as compensation expenses in the financial statements based on the fair values of the stock awards on the grant date. That expense is recognized over the period required to provide services in exchange for the award, known as the requisite service period (usually the vesting period ).
Common Stock Purchase Warrants and Derivative Financial Instruments	Common Stock Purchase Warrants and Derivative Financial Instruments Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses the classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.
Basic and Diluted Net Loss per Common Share	Basic and Diluted Net Loss per Common Share Pursuant to ASC 260, “Earnings Per Share,” basic net income and net loss per share are computed by dividing the net income and net loss by the weighted average number of common shares outstanding. Diluted net income and net loss per share is the same as basic net income and net loss per share when their inclusion would have an anti-dilutive effect due to our continuing net losses. The following outstanding stock was excluded from the computation of diluted net loss per share as the result was anti-dilutive. SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE 2024 2023 March 31, 2024 2023 (Shares) (Shares) Series C Preferred Stock 3,384,135 3,384,135 Warrants 2,358,101 2,358,101 Total 5,742,236 5,742,236 Anti-dilutive shares 5,742,236 5,742,236
Foreign Currency Translations	Foreign Currency Translations The functional currency of the Company’s international subsidiaries is generally their local currency of Great British Pounds (GBP). Local currency assets and liabilities are translated at the exchange rates on the balance sheet date, and local currency revenues and expenses are translated at weighted average exchange rates during the period. Equity accounts are translated at historical rates. The resulting translation adjustments are recorded directly into accumulated other comprehensive income. SCHEDULE OF FOREIGN CURRENCY TRANSLATION ADJUSTMENTS 2024 2023 2023 March 31, December 31, 2024 2023 2023 Period-end GBP£: U.S.$ exchange rate 1.2632 1.2341 1.2731 Weighted average GBP£: U.S.$ exchange rate 1.2684 1.2152 1.2441 Aggregate transaction gains or losses, including gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of certain inter-company balances, are included in the statement of operations as other income and expense. Gains on foreign exchange transactions totaling $ 5,210 19,142
Income Taxes	Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes.” The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount believed more likely than not to be realized. As of March 31, 2024, and December 31, 2023, the Company did not have any amounts recorded pertaining to uncertain tax positions. UK Taxes We do not consider ourselves to be engaged in a trade or business in the UK and, as such, do not expect to be subject to UK corporate income taxation. We have subsidiaries based in the UK that are subject to the tax laws of that country. Under current law, those subsidiaries are taxed at the applicable corporate income tax rates. Should any UK subsidiaries be deemed to undertake business activities in the US, they would be subject to US corporate income tax in respect of their US activities only. Relief would then be available against the UK tax liabilities in respect of the overseas taxes arising from US activities. At present, this is not applicable as our UK subsidiaries only undertake activities in the UK. Our UK subsidiaries file separate UK income tax returns. UK Tax Risk Companies that are incorporated outside the UK may become subject to UK taxes in a number of circumstances, including circumstances in which (1) they are deemed resident in the UK for tax purposes by reason of their central management and control being exercised from the UK or (2) they are treated as carrying on a trade, investing or carrying on any other business activity in the UK, whether or not through a UK Permanent Establishment (“PE”). In addition, the Finance Act 2015 introduced a new tax known as the diverted profits tax (“DPT”), which is charged at 25% of any “taxable diverted profit.”. The DPT has had an effect since April 1, 2015, and may apply in circumstances including (1) where arrangements are designed to ensure that a non-UK resident company does not carry on a trade in the UK through a PE; and (2) where a tax reduction is obtained through the involvement of entities or transactions lacking economic substance. We intend to operate in such a manner that none of our companies should be subject to the UK DPT and that none of our companies (other than those companies incorporated in the UK) should: (1) be treated as resident in the UK for tax purposes; (2) carry on a trade, invest or carry on any other business activity in the UK (whether or not through a UK PE). However, this result is based on certain legal and factual determinations, and since the scope and the basis upon which the DPT will be applied by HM Revenue & Customs (“HMRC”) in the UK remains uncertain and since applicable law and regulations do not conclusively define the activities that constitute conducting a trade, investment or business activity in the UK (whether or not through a UK PE), and since we cannot exclude the possibility that there will be a change in law that adversely affects the analysis, HMRC might successfully assert a contrary position. The terms of an income tax treaty between the UK and the home country of the relevant Bubblr subsidiary, if any, could contain additional protections against UK tax. Any arrangements between UK-resident entities of Bubblr and other entities of Bubblr are subject to the UK transfer pricing regime. Consequently, if any agreement between a UK resident entity of Bubblr and any other Bubblr entity (whether that entity is resident in or outside of the UK) is found not to be on arm’s length terms and, as a result, a UK tax advantage is being obtained, an adjustment will be required to compute UK taxable profits as if such an agreement were on arm’s length terms. Any transfer pricing adjustment could adversely impact the tax charge incurred by the relevant UK resident entities of Bubblr.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial statements.
Reclassifications	Reclassifications Certain accounts have been reclassified in prior periods to conform to current period presentation. Compensation expense that was previously reported separately has been combined with general and administrative expenses in the Consolidated Statements of Operations and Comprehensive Loss for all periods presented.

SIGNIFICANT ACCOUNTING POLICI_3

SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
SCHEDULE OF SEGMENT REPORTING	SCHEDULE OF SEGMENT REPORTING Three Months Ended March 31, Net sales: 2024 2023 North America $ 1,504 $ - Europe - - Totals $ 1,504 $ - Net sales $ 1,504 $ - Long-lived assets, net (property and equipment and intangible assets): March 31, 2024 June 30, 2023 North America $ - $ - Europe 2,349 31,302 Totals $ 2,349 $ 31,302 Long-lived assets, net $ 2,349 $ 31,302
SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE	The following outstanding stock was excluded from the computation of diluted net loss per share as the result was anti-dilutive. SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE 2024 2023 March 31, 2024 2023 (Shares) (Shares) Series C Preferred Stock 3,384,135 3,384,135 Warrants 2,358,101 2,358,101 Total 5,742,236 5,742,236 Anti-dilutive shares 5,742,236 5,742,236
SCHEDULE OF FOREIGN CURRENCY TRANSLATION ADJUSTMENTS	SCHEDULE OF FOREIGN CURRENCY TRANSLATION ADJUSTMENTS 2024 2023 2023 March 31, December 31, 2024 2023 2023 Period-end GBP£: U.S.$ exchange rate 1.2632 1.2341 1.2731 Weighted average GBP£: U.S.$ exchange rate 1.2684 1.2152 1.2441

OTHER RECEIVABLES (Tables)

OTHER RECEIVABLES (Tables)	3 Months Ended
	Mar. 31, 2024
Credit Loss [Abstract]
SCHEDULE OF OTHER RECEIVABLES	Other receivables consisted of the following: SCHEDULE OF OTHER RECEIVABLES March 31, December 31, 2024 2023 Deposit $ 200 $ 200 UK R&D credit 79,582 80,205 UK VAT receivable 9,155 7,098 Total other receivables $ 88,937 $ 87,503

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	3 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
SCHEDULE OF PROPERTY PLANT AND EQUIPMENT	Property and equipment consisted of the following: SCHEDULE OF PROPERTY PLANT AND EQUIPMENT Motor Vehicles Computer Equipment Office Equipment Total Cost At December 31, 2023 $ 53,470 $ 29,646 $ - $ 83,116 Additions - - - - Disposals (53,054 ) (3,502 ) - (56,556 ) Effects of currency translation (416 ) (231 ) - (647 ) At March 31, 2024 - 25,913 - 25,913 Less accumulated depreciation At December 31, 2023 $ 25,997 $ 25,817 $ - $ 51,814 Depreciation expense 1,053 1,449 - 2,502 Disposals (26,847 ) (3,502 ) - (30,349 ) Effects of currency translation (203 ) (200 ) - (403 ) At March 31, 2024 - 23,564 - 23,564 Net book value At March 31, 2024 - 2,349 - 2,349 At December 31, 2023 $ 27,473 $ 3,829 $ - $ 31,302

INTANGIBLE ASSETS (Tables)

INTANGIBLE ASSETS (Tables)	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
SCHEDULE OF INTANGIBLE ASSETS	Intangible assets consisted of the following: SCHEDULE OF INTANGIBLE ASSETS Patents Trademarks Intellectual Property Capitalized Acquisition Costs Total Cost: At December 31, 2023 $ 220,926 $ 36,558 $ 3,109,540 $ 45,745 $ 3,412,769 Cost, beginning balance $ 220,926 $ 36,558 $ 3,109,540 $ 45,745 $ 3,412,769 Additions 15,139 427 - - 15,566 Effects of currency translation (1,718 ) (285 ) (24,180 ) - (26,183 ) At March 31, 2024 $ 234,347 $ 36,700 $ 3,085,360 $ 45,745 $ 3,402,152 Cost, ending balance $ 234,347 $ 36,700 $ 3,085,360 $ 45,745 $ 3,402,152 Less accumulated amortization: At December 31, 2023 $ 8,541 $ - $ 1,940,736 $ 6,864 $ 1,956,141 Accumulated amortization, beginning balance $ 8,541 $ - $ 1,940,736 $ 6,864 $ 1,956,141 Amortization expense 1,630 - 49,287 572 51,489 Effects of currency translation (70 ) - (15,089 ) - (15,159 ) At March 31, 2024 $ 10,101 $ - $ 1,974,934 $ 7,436 1,992,471 Accumulated amortization, ending balance $ 10,101 $ - $ 1,974,934 $ 7,436 1,992,471 Net book value At March 31, 2024 $ 224,246 $ 36,700 $ 1,110,426 $ 38,309 $ 1,409,681 At December 31, 2023 $ 212,385 $ 36,558 $ 1,168,804 $ 38,881 $ 1,456,628 Net book value $ 212,385 $ 36,558 $ 1,168,804 $ 38,881 $ 1,456,628

ACCRUED LIABILITIES (Tables)

ACCRUED LIABILITIES (Tables)	3 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
SCHEDULE OF ACCRUED LIABILITIES	Accrued liabilities consisted of the following: SCHEDULE OF ACCRUED LIABILITIES March 31, December 31, 2024 2023 Director fees $ 120,000 $ 90,000 Dividends payable 86,688 65,016 Other accruals 49,892 76,945 Settlement payable 166,986 166,986 Wages and salaries 682,508 544,060 Total Accrued liabilities $ 1,106,074 $ 943,007

LOANS PAYABLE TO RELATED PART_2

LOANS PAYABLE TO RELATED PARTIES (Tables)	3 Months Ended
	Mar. 31, 2024
Related Party [Member]
Defined Benefit Plan Disclosure [Line Items]
SCHEDULE OF LOANS PAYABLE TO RELATED PARTIES	The Company had the following loans payable to related parties: SCHEDULE OF LOANS PAYABLE TO RELATED PARTIES March 31, December 31, 2024 2023 Loan 1 (May 23, 2022) – Loan payable to Stephen Morris $ 229,575 $ 125,910 Loan 2 (September 7, 2022) – Loan payable to Stephen Morris 548,341 552,639 September 8, 2022 – Loan payable to Director 34,395 32,337 Total loan payable to related parties 812,311 710,886 Less – current portion 263,970 158,247 Total – noncurrent $ 548,341 $ 552,639

WARRANT LIABILITY (Tables)

WARRANT LIABILITY (Tables)	3 Months Ended
	Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
SCHEDULE OF ESTIMATED FAIR VALUES OF WARRANT LIABILITIES MEASURED ON A RECURRING BASIS	For the period ended March 31, 2024, the estimated fair values of the warrant liabilities measured on a recurring basis are as follows : SCHEDULE OF ESTIMATED FAIR VALUES OF WARRANT LIABILITIES MEASURED ON A RECURRING BASIS Three Months Ended March 31, 2024 Expected term 1.59 2.50 Expected average volatility 177 220 % Expected dividend yield 8.33 % Risk-free interest rate 1.50 5.46 %
SUMMARY OF CHANGES IN WARRANT LIABILITIES	The following table summarizes the changes in the warrant liabilities during the three months ended March 31, 2024, and year ended December 31, 2023: SUMMARY OF CHANGES IN WARRANT LIABILITIES Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Warrant liability December 31, 2022 $ 198,479 Addition of new warrants - Change in fair value of warrant liability (159,363 ) Warrant liability as of December 31, 2023 $ 39,116 Addition of new warrants $ - Change in fair value of warrant liability 1,251 Warrant liability as of March 31, 2024 $ 40,367

STOCKHOLDERS_ EQUITY (Tables)

STOCKHOLDERS’ EQUITY (Tables)	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
SUMMARY OF WARRANTS ACTIVITY	A summary of activity during the three-month period ended March 31, 2024, follows: SUMMARY OF WARRANTS ACTIVITY Warrants Outstanding Weighted Average Number of Weighted Average Remaining life Warrants Exercise Price (years) Outstanding, December 31, 2023 2,538,101 $ 0.32 4.27 Granted - - - Exercised - - - Forfeited/canceled - - - Outstanding, March 31, 2024 2,538,101 $ 0.32 3.52 Exercisable Warrants, March 31, 2024 2,538,101 $ 0.32 3.52
SUMMARY OF INFORMATION RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS	The following table summarizes information relating to outstanding and exercisable warrants as of March 31, 2024: SUMMARY OF INFORMATION RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS Warrants Outstanding Warrants Exercisable Number of Weighted Average Remaining Contractual life (in years) Weighted Average Number of Shares Weighted Average 941,599 3.43 $ 0.34 941,599 $ 0.34 472,205 3.44 0.34 472,205 0.34 562,149 3.57 0.35 562,149 0.35 281,074 3.65 0.22 281,074 0.22 281,074 3.74 0.22 281,074 0.22 2,538,101 3.52 $ 0.32 2,538,101 $ 0.32
SUMMARY OF STOCK OPTION ACTIVITY	The following table summarizes the stock options activity for the three months ended March 31, 2024: SUMMARY OF STOCK OPTION ACTIVITY Number of Shares Weighted-Average Exercise Price (per share) Outstanding as of December 31, 2023 14,400,000 $ 0.1560 Granted - - Exercised - - Forfeited or expired - - Outstanding at March 31, 2023 14,400,000 $ 0.1560 Exercisable at March 31, 2024 10,788,000 Weighted-average fair value of options granted in the period $ 0.1560
SCHEDULE OF THE WEIGHTED AVERAGE FAIR VALUE OF STOCK OPTIONS	The weighted average fair value of stock options granted is based on the Black-Scholes option pricing model using the following weighted average assumptions. SCHEDULE OF THE WEIGHTED AVERAGE FAIR VALUE OF STOCK OPTIONS Three Month March 31, 2024 Expected life in years 9.01 Risk-free interest rate 4.20 % Annual forfeiture rate 0 % Volatility 221 % Expected dividend yield 0 %
SCHEDULE OF NON-VESTED SHARES	The following table summarizes certain information regarding the Company’s non-vested shares as of the three-month period ended March 31, 2024: SCHEDULE OF NON-VESTED SHARES Number of Shares Weighted-Average Non-vested as of December 31, 2023 14,400,000 $ 0.1560 Granted - - Forfeited or expired - - Vested (10,788,000 ) 0.1560 Non-vested as of March 31, 2024 3,612,000 $ 0.1560
SUMMARY OF STOCK OPTION ACTIVITY OUTSTANDING AND EXERCISABLE	The following table summarizes the stock options exercisable for the three-month period ended March 31, 2024: SUMMARY OF STOCK OPTION ACTIVITY OUTSTANDING AND EXERCISABLE Options Options Outstanding Exercisable Number of shares 14,400,000 10,788,000 Weighted-average contractual life in years 9.01 9.01 Weighted-average exercise price $ 0.1560 $ 0.1614 Intrinsic value $ 0.00 $ 0.00

SCHEDULE OF SEGMENT REPORTING (

SCHEDULE OF SEGMENT REPORTING (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Jun. 30, 2023
Net sales	$ 1,504
Long-lived assets, net	2,349		$ 31,302	$ 31,302
North America [Member]
Net sales	1,504
Long-lived assets, net
Europe [Member]
Net sales
Long-lived assets, net	$ 2,349			$ 31,302

ORGANIZATION, BUSINESS AND LI_2

ORGANIZATION, BUSINESS AND LIQUIDITY (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Date of incorporation	Oct. 22, 2019
Comprehensive income net of tax	$ 446,391	$ 273,478
Accumulated deficit	(16,095,315)		$ (15,612,775)
Working capital	$ 1,678,521
UWRL [Member]
Ownership percentage	100%

SCHEDULE OF COMPUTATION OF DILU

SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE (Details) - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive shares	5,742,236	5,742,236
Series C Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive shares	3,384,135	3,384,135
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive shares	2,358,101	2,358,101

SCHEDULE OF FOREIGN CURRENCY TR

SCHEDULE OF FOREIGN CURRENCY TRANSLATION ADJUSTMENTS (Details)	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023
Accounting Policies [Abstract]
Period-end GBP£: U.S.$ exchange rate	1.2632	1.2731	1.2341
Weighted average GBP£: U.S.$ exchange rate	1.2684	1.2441	1.2152

SIGNIFICANT ACCOUNTING POLICI_4

SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Accounting Policies [Abstract]
impairment of long-lived assets	$ 0		$ 6,367
Warrant derivative liability	40,367		$ 39,116
Foreign currency transaction loss	$ 5,210	$ 19,142

SCHEDULE OF OTHER RECEIVABLES (

SCHEDULE OF OTHER RECEIVABLES (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Credit Loss [Abstract]
Deposit	$ 200	$ 200
UK R&D credit	79,582	80,205
UK VAT receivable	9,155	7,098
Total other receivables	$ 88,937	$ 87,503

SCHEDULE OF PROPERTY PLANT AND

SCHEDULE OF PROPERTY PLANT AND EQUIPMENT (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Jun. 30, 2023
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross, beginning balance	$ 83,116
Property plant and equipment, additions
Property plant and equipment, Disposals	(56,556)
Effects of currency translation	(647)
Property, plant and equipment, gross balance	25,913
Accumulated depreciation, beginning balance	51,814
Depreciation expense	2,502	$ 3,106
Disposals	(30,349)
Depreciation expense	(403)
Accumulated depreciation, Ending balance	23,564
Property, plant and equipment, net	2,349		$ 31,302	$ 31,302
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross, beginning balance	53,470
Property plant and equipment, additions
Property plant and equipment, Disposals	(53,054)
Effects of currency translation	(416)
Property, plant and equipment, gross balance
Accumulated depreciation, beginning balance	25,997
Depreciation expense	1,053
Disposals	(26,847)
Depreciation expense	(203)
Accumulated depreciation, Ending balance
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross, beginning balance	29,646
Property plant and equipment, additions
Property plant and equipment, Disposals	(3,502)
Effects of currency translation	(231)
Property, plant and equipment, gross balance	25,913
Accumulated depreciation, beginning balance	25,817
Depreciation expense	1,449
Disposals	(3,502)
Depreciation expense	(200)
Accumulated depreciation, Ending balance	23,564
Property, plant and equipment, net	2,349		3,829
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross, beginning balance
Property plant and equipment, additions
Property plant and equipment, Disposals
Effects of currency translation
Property, plant and equipment, gross balance
Accumulated depreciation, beginning balance
Depreciation expense
Disposals
Depreciation expense
Accumulated depreciation, Ending balance
Property, plant and equipment, net
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, net			$ 27,473

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 2,502	$ 3,106
Loss on disposal	$ 9,317

SCHEDULE OF INTANGIBLE ASSETS (

SCHEDULE OF INTANGIBLE ASSETS (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Cost, beginning balance	$ 3,412,769
Additions	15,566
Effects of currency translation	(26,183)
Cost, ending balance	3,402,152
Accumulated amortization, beginning balance	1,956,141
Amortization expense	51,489	$ 56,521
Effects of currency translation	(15,159)
Accumulated amortization, ending balance	1,992,471
Net book value	1,409,681		$ 1,456,628
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Cost, beginning balance	220,926
Additions	15,139
Effects of currency translation	(1,718)
Cost, ending balance	234,347
Accumulated amortization, beginning balance	8,541
Amortization expense	1,630
Effects of currency translation	(70)
Accumulated amortization, ending balance	10,101
Net book value	224,246		212,385
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Cost, beginning balance	36,558
Additions	427
Effects of currency translation	(285)
Cost, ending balance	36,700
Accumulated amortization, beginning balance
Amortization expense
Effects of currency translation
Accumulated amortization, ending balance
Net book value	36,700		36,558
Intellectual Property [Member]
Finite-Lived Intangible Assets [Line Items]
Cost, beginning balance	3,109,540
Additions
Effects of currency translation	(24,180)
Cost, ending balance	3,085,360
Accumulated amortization, beginning balance	1,940,736
Amortization expense	49,287
Effects of currency translation	(15,089)
Accumulated amortization, ending balance	1,974,934
Net book value	1,110,426		1,168,804
Capitalized Acquisition Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Cost, beginning balance	45,745
Additions
Effects of currency translation
Cost, ending balance	45,745
Accumulated amortization, beginning balance	6,864
Amortization expense	572
Effects of currency translation
Accumulated amortization, ending balance	7,436
Net book value	$ 38,309		$ 38,881

INTANGIBLE ASSETS (Details Narr

INTANGIBLE ASSETS (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 51,489	$ 56,521
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets useful lives	20 years
Amortization expense	$ 1,630
Intellectual Property [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets useful lives	7 years
Amortization expense	$ 49,287

SCHEDULE OF ACCRUED LIABILITIES

SCHEDULE OF ACCRUED LIABILITIES (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Director fees	$ 120,000	$ 90,000
Dividends payable	86,688	65,016
Other accruals	49,892	76,945
Settlement payable	166,986	166,986
Wages and salaries	682,508	544,060
Total Accrued liabilities	$ 1,106,074	$ 943,007

SCHEDULE OF LOANS PAYABLE TO RE

SCHEDULE OF LOANS PAYABLE TO RELATED PARTIES (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Stephen Morris [Member] | Loan One [Member]
Short-Term Debt [Line Items]
Total loan payable to related parties	$ 229,575	$ 125,910
Stephen Morris [Member] | Loan Two [Member]
Short-Term Debt [Line Items]
Total loan payable to related parties	548,341	552,639
Director [Member]
Short-Term Debt [Line Items]
Total loan payable to related parties	34,395	32,337
Related Party [Member]
Short-Term Debt [Line Items]
Total loan payable to related parties	812,311	710,886
Less – current portion	263,970	158,247
Total – noncurrent	$ 548,341	$ 552,639

LOANS PAYABLE TO RELATED PART_3

LOANS PAYABLE TO RELATED PARTIES (Details Narrative)

3 Months Ended

Dec. 27, 2023 USD ($) $ / shares shares

Dec. 20, 2022 USD ($)

Dec. 20, 2022 EUR (€)

Sep. 06, 2022 USD ($)

Sep. 06, 2022 EUR (€)

Mar. 31, 2024 USD ($)

Mar. 31, 2023 USD ($)

Mar. 31, 2024 EUR (€)

Dec. 31, 2023 USD ($)

Dec. 31, 2023 EUR (€)

Sep. 08, 2022 USD ($)

Sep. 08, 2022 EUR (€)

Sep. 07, 2022 USD ($)

Sep. 07, 2022 EUR (€)

Short-Term Debt [Line Items]

Debt instrument face amount

$ 550,468

€ 434,060

Interest expense

$ 3,592

$ 1,129

Mr. Stephen Morris [Member]

Short-Term Debt [Line Items]

Promissory notes payable

$ 821,431.87

Common stock, issued | shares

2,489,186

Conversion price | $ / shares

$ 0.33

Debt instrument face amount

$ 501,049

€ 434,060

Unsecured interest

0%

0%

Paul Morrissey [Member]

Short-Term Debt [Line Items]

Debt instrument face amount

$ 32,337

€ 25,401

Original issue discount

$ 6,954

€ 5,700

Interest rate

2.85%

2.85%

Debt instrument outstanding

34,395

€ 27,229

$ 32,337

€ 25,401

Interest expense

$ 1,750

$ 0

Second Amendment [Member]

Short-Term Debt [Line Items]

Principal of loan

$ 60,000

€ 52,088

Third Amendment [Member]

Short-Term Debt [Line Items]

Principal of loan

$ 71,540

€ 59,543

Assignment of advances receivable

$ 71,540

€ 59,543

Founder Loan [Member]

Short-Term Debt [Line Items]

Debt instrument call feature

On May 23, 2022, the Company entered an amendment to the Loan Agreement between Bubblr Limited and Mr. Morris to change the loan from a demand loan to have a maturity date on the earlier of (i) the completion of an offering by Bubblr, Inc., in the amount of no less than $7,500,000 in a public offering, or (ii) two years from the date of the amendment.

Debt instrument payment terms

In addition, on a date no later than five (5) business days from the completion of bridge financing of no less than $1.5 million USD, the Company shall pay to Mr. Morris an amount equal to £115,000 GBP as an installment payment on the principal of the Loan, and the balance of the principal of the Loan shall be paid at the Maturity Date

SCHEDULE OF ESTIMATED FAIR VALU

SCHEDULE OF ESTIMATED FAIR VALUES OF WARRANT LIABILITIES MEASURED ON A RECURRING BASIS (Details)	Mar. 31, 2024
Measurement Input, Expected Term [Member] | Minimum [Member]
Derivative [Line Items]
Expected term	1 year 7 months 2 days
Measurement Input, Expected Term [Member] | Maximum [Member]
Derivative [Line Items]
Expected term	2 years 6 months
Measurement Input, Price Volatility [Member] | Minimum [Member]
Derivative [Line Items]
Warrants and rights outstanding, measurement input	177
Measurement Input, Price Volatility [Member] | Maximum [Member]
Derivative [Line Items]
Warrants and rights outstanding, measurement input	220
Measurement Input, Expected Dividend Rate [Member]
Derivative [Line Items]
Warrants and rights outstanding, measurement input	8.33
Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]
Derivative [Line Items]
Warrants and rights outstanding, measurement input	1.50
Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]
Derivative [Line Items]
Warrants and rights outstanding, measurement input	5.46

SUMMARY OF CHANGES IN WARRANT L

SUMMARY OF CHANGES IN WARRANT LIABILITIES (Details) - Fair Value, Inputs, Level 3 [Member] - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Platform Operator, Crypto Asset [Line Items]
Warrant liability, Balance	$ 39,116	$ 198,479
Addition of new warrants
Change in fair value of warrant liability	1,251	(159,363)
Warrant liability, Balance	$ 40,367	$ 39,116

SUMMARY OF WARRANTS ACTIVITY (D

SUMMARY OF WARRANTS ACTIVITY (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Equity [Abstract]
Number of Warrants outstanding Beginning balance	2,538,101
Weighted Average Exercise Price Outstanding	$ 0.32
Weighted Average Remaining life (years)	3 years 6 months 7 days	4 years 3 months 7 days
Number of Warrants Granted
Weighted Average Exercise Price Granted
Number of Warrants Exercised
Weighted Average Exercise Price Exercised
Number of Warrants Forfeited/canceled
Weighted Average Exercise Price Forfeited/canceled
Number of Warrants outstanding ending balance	2,538,101	2,538,101
Weighted Average Exercise Price Outstanding	$ 0.32	$ 0.32
Number of Warrants Exercisable	2,538,101
Weighted Average Exercise Price Exercisable	$ 0.32
Weighted Average Remaining life (years) Exercisable Warrants	3 years 6 months 7 days

SUMMARY OF INFORMATION RELATING

SUMMARY OF INFORMATION RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS (Details) - $ / shares	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Class of Warrant or Right [Line Items]
Number of Warrants, Warrants Outstanding	2,538,101	2,538,101
Weighted Average Remaining life Contractual life (years), Warrants Outstanding	3 years 6 months 7 days
Weighted Average Exercise Price, Warrants Outstanding	$ 0.32	$ 0.32
Number of Shares, Warrants Exercisable	2,538,101
Weighted Average Exercise Price, Warrants Exercisable	$ 0.32
Warrants One [Member]
Class of Warrant or Right [Line Items]
Number of Warrants, Warrants Outstanding	941,599
Weighted Average Remaining life Contractual life (years), Warrants Outstanding	3 years 5 months 4 days
Weighted Average Exercise Price, Warrants Outstanding	$ 0.34
Number of Shares, Warrants Exercisable	941,599
Weighted Average Exercise Price, Warrants Exercisable	$ 0.34
Warrants Two [Member]
Class of Warrant or Right [Line Items]
Number of Warrants, Warrants Outstanding	472,205
Weighted Average Remaining life Contractual life (years), Warrants Outstanding	3 years 5 months 8 days
Weighted Average Exercise Price, Warrants Outstanding	$ 0.34
Number of Shares, Warrants Exercisable	472,205
Weighted Average Exercise Price, Warrants Exercisable	$ 0.34
Warrants Three [Member]
Class of Warrant or Right [Line Items]
Number of Warrants, Warrants Outstanding	562,149
Weighted Average Remaining life Contractual life (years), Warrants Outstanding	3 years 6 months 25 days
Weighted Average Exercise Price, Warrants Outstanding	$ 0.35
Number of Shares, Warrants Exercisable	562,149
Weighted Average Exercise Price, Warrants Exercisable	$ 0.35
Warrants Four [Member]
Class of Warrant or Right [Line Items]
Number of Warrants, Warrants Outstanding	281,074
Weighted Average Remaining life Contractual life (years), Warrants Outstanding	3 years 7 months 24 days
Weighted Average Exercise Price, Warrants Outstanding	$ 0.22
Number of Shares, Warrants Exercisable	281,074
Weighted Average Exercise Price, Warrants Exercisable	$ 0.22
Warrants Five [Member]
Class of Warrant or Right [Line Items]
Number of Warrants, Warrants Outstanding	281,074
Weighted Average Remaining life Contractual life (years), Warrants Outstanding	3 years 8 months 26 days
Weighted Average Exercise Price, Warrants Outstanding	$ 0.22
Number of Shares, Warrants Exercisable	281,074
Weighted Average Exercise Price, Warrants Exercisable	$ 0.22

SUMMARY OF STOCK OPTION ACTIVIT

SUMMARY OF STOCK OPTION ACTIVITY (Details)	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Equity [Abstract]
Options Outstanding | shares	14,400,000
Weighted-Average Exercise Price outstanding | $ / shares	$ 0.1560
Options Outstanding Grants | shares
Weighted-Average Exercise Price Grants | $ / shares
Options Outstanding Exercised | shares
Weighted-Average Exercise Price Exercised | $ / shares
Forfeited or expired | shares
Weighted-Average Exercise Price Forfeited or expired | $ / shares
Options Outstanding | shares	14,400,000
Weighted-Average Exercise Price outstanding | $ / shares	$ 0.1560
Exercisable shares | shares	10,788,000
Weighted average options granted | $ / shares	$ 0.1560

SCHEDULE OF THE WEIGHTED AVERAG

SCHEDULE OF THE WEIGHTED AVERAGE FAIR VALUE OF STOCK OPTIONS (Details)	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Expected life	9 years 3 days
Risk-free interest rate	4.20%
Annual forfeiture rate	0%
Volatility	221%
Expected dividend yield	0%

SCHEDULE OF NON-VESTED SHARES (

SCHEDULE OF NON-VESTED SHARES (Details)	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Equity [Abstract]
Number of shares | shares	14,400,000
Weighted average | $ / shares	$ 0.1560
Number of shares granted | shares
Weighted average granted | $ / shares
Number of shares forfeited or expired | shares
Weighted average forfeited or expired | $ / shares
Number of shares vested | shares	(10,788,000)
Weighted average vested | $ / shares	$ 0.1560
Number of shares | shares	3,612,000
Weighted average | $ / shares	$ 0.1560

SUMMARY OF STOCK OPTION ACTIV_2

SUMMARY OF STOCK OPTION ACTIVITY OUTSTANDING AND EXERCISABLE (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Equity [Abstract]
Options outstanding number of shares	14,400,000	14,400,000
Options exercisable number of shares	10,788,000
Options outstanding weighted-average contractual life in years	9 years 3 days
Options exercisable weighted-average contractual life in years	9 years 3 days
Options outstanding weighted-average exercise price	$ 0.1560	$ 0.1560
Options exercisable weighted-average exercise price	$ 0.1614
Options outstanding Intrinsic value	$ 0
Options exercisable Intrinsic value	$ 0

STOCKHOLDERS_ EQUITY (Details N

STOCKHOLDERS’ EQUITY (Details Narrative)

3 Months Ended

Apr. 01, 2023

Mar. 04, 2023 USD ($) $ / shares shares

Sep. 24, 2022 USD ($) shares

Sep. 07, 2022 USD ($) shares

May 25, 2022 USD ($) shares

Apr. 24, 2022 USD ($) shares

Mar. 09, 2022 USD ($) shares

Mar. 04, 2022 USD ($) shares

Mar. 31, 2024 USD ($) $ / shares shares

Mar. 31, 2023 USD ($)

Dec. 31, 2023 $ / shares shares

Sep. 07, 2022 EUR (€)

Class of Stock [Line Items]

Preferred stock, shares authorized

25,000,000

Preferred stock, per share | $ / shares

$ 0.001

Warrant shares

2,538,101

2,538,101

Debt instrument face amount

$ 550,468

€ 434,060

Residual loss | $

28,043

Gain (Loss) on Securitization of Financial Assets | $

$ 95,768

Common stock, shares authorized

3,000,000,000

3,000,000,000

Common stock, par value | $ / shares

$ 0.01

$ 0.01

Stock issued during period value | $

$ 285,338

Dividends value | $

$ 22,133

Common stock, shares issued

159,690,447

159,690,447

Common stock, shares outstanding

159,690,447

159,690,447

Option vest description

Company granted options for purchasing our Common stock to executives, management, and a non-executive director as consideration for time served. The Board of Directors determine the terms of the stock option grants that are consistent with our 2022 Equity Incentive Plan.

Option grant description

Our stock option grant general policy is that options vest 40% after 90 days of service, and the remaining options vest monthly over two years. The maximum term is ten years.

Unrecognized compensation costs | $

$ 108,990

Unrecognized compensation costs | $

$ 517,783

Bubblr Limited And Morris [Member]

Class of Stock [Line Items]

Investment company fee waiver terms

200,000

GHS [Member]

Class of Stock [Line Items]

Convertible preferred stock value | $

$ 700,000

Preferred stock, share subscriptions

700

Warrant shares

941,599

Gross proceeds | $

$ 266,000

Shares of common stock to Proactive

281,000

Proactive [Member]

Class of Stock [Line Items]

Preferred stock, share subscriptions

160

Warrant shares

472,205

Shares of common stock to Proactive

64,220

Proactive Two [Member]

Class of Stock [Line Items]

Gross proceeds | $

$ 290,000

GHS Tranche 2 [Member]

Class of Stock [Line Items]

Warrant shares

562,149

Gross proceeds | $

$ 184,000

GHS Tranche 3 [Member]

Class of Stock [Line Items]

Gross proceeds | $

$ 92,000

GHS Tranche 4 [Member]

Class of Stock [Line Items]

Warrant shares

281,074

Gross proceeds | $

$ 92,000

Proactive Total [Member]

Class of Stock [Line Items]

Gross proceeds | $

$ 789,000

Warrant Allocated [Member]

Class of Stock [Line Items]

Gross proceeds | $

$ 721,275

Consultancy Services [Member]

Class of Stock [Line Items]

Stock issued during period shares

625,000

Stock issued during period value | $

$ 100,000

Professional Services [Member]

Class of Stock [Line Items]

Stock issued during period shares

500,000

Stock issued during period value | $

$ 65,000

Investor Relations [Member]

Class of Stock [Line Items]

Stock issued during period shares

1,455,784

Stock issued during period value | $

$ 285,338

Warrant [Member]

Class of Stock [Line Items]

Intrinsic value | $

$ 0

Series C Preferred Stock [Member]

Class of Stock [Line Items]

Preferred stock, shares authorized

2,000

2,000

2,000

Preferred stock, per share | $ / shares

$ 1,200

$ 0.001

$ 0.001

Dividend rate

8%

Preferred stock conversion basis

Each share of the Series C Convertible Preferred Stock is convertible, at any time and from time to time from and after the issuance at the option of the Holder thereof, into that number of shares of Common Stock (subject to Beneficial Ownership Limitations) determined by dividing the Stated Value of $1,200 of such share by the Conversion Price of $0.3202.

Preferred stock, liquidation preference value | $

$ 1,200

Conversion Price | $ / shares

$ 0.3202

Preferred stock, shares issued

903

903

Preferred stock, shares outstanding

903

903

Dividends shares

311,159

Dividends value | $

$ 43,805

Series C Preferred Stock [Member] | Redeemed After 90 Days [Member]

Class of Stock [Line Items]

Debt instrument, redemption, description

The Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days of written notice at a price equal to 120% of the Stated Value together with any accrued but unpaid dividends; and

Series C Preferred Stock [Member] | GHS [Member]

Class of Stock [Line Items]

Warrant shares percent

75%

Series C Preferred Stock [Member] | Tranche 1 [Member]

Class of Stock [Line Items]

Stock issued during period shares

300

Series C Preferred Stock [Member] | Commitment Shares [Member] | GHS [Member]

Class of Stock [Line Items]

Stock issued during period shares

35

Series C Preferred Stock [Member] | Commitment Shares [Member] | Proactive [Member]

Class of Stock [Line Items]

Stock issued during period shares

8

Series C Preferred Stock [Member] | Proactive [Member]

Class of Stock [Line Items]

Stock issued during period shares

168

Warrant shares percent

75%

Series C Preferred Stock [Member] | GHS Tranche 2 [Member]

Class of Stock [Line Items]

Stock issued during period shares

200

Series C Preferred Stock [Member] | GHS Tranche 3 [Member]

Class of Stock [Line Items]

Stock issued during period shares

100

Series C Preferred Stock [Member] | GHS Tranche 4 [Member]

Class of Stock [Line Items]

Stock issued during period shares

100

Series C Preferred Stock [Member] | Preferred Stock [Member]

Class of Stock [Line Items]

Shares of common stock to Proactive

345,220

Interest expense | $

$ 71,703

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)									3 Months Ended	12 Months Ended
	Jul. 06, 2023	Jul. 01, 2023	Jun. 15, 2023	May 12, 2023	Apr. 06, 2023	Apr. 01, 2023	Feb. 14, 2023	Jan. 31, 2023	Mar. 31, 2024	Dec. 31, 2023
Other Commitments [Line Items]
Non-vested share options									10,788,000
Launchpad IR [Member]
Other Commitments [Line Items]
Received cash			$ 3,000
Stephen Morris [Member]
Other Commitments [Line Items]
Compensate salary						$ 180,000
Compensate salary						60%
Share-Based compensation arrangement description						Company agreed to grant Mr. Morris an option to purchase 3,360,000 shares of common stock at $0.187 per share (628,320) under the 2022 Incentive Plan
Chetwood [Member]
Other Commitments [Line Items]
Share-Based compensation arrangement description				Company agreed to grant Mr. Chetwood an option to purchase 3,360,000 shares of common stock at $0.1625 per share ($546,000), with 40% vesting after 90 days of service and 60% vesting monthly over the following two years
Consulting Agreement [Member] | Beyond Media SEZC [Member]
Other Commitments [Line Items]
Stock compensation value							$ 7,000
Shares of common stock							1,000,000
Common stock value							$ 180,000
Separation Agreements [Member] | Rik Willard [Member]
Other Commitments [Line Items]
Number of restricted stock								$ 116,000	$ 79,250
Amended Employment Agreement [Member] | Maximum [Member]
Other Commitments [Line Items]
Annual payment									450,000
Amended Employment Agreement [Member] | Minimum [Member]
Other Commitments [Line Items]
Annual payment									90,000
Amended Employment Agreement [Member] | Rik Willard [Member]
Other Commitments [Line Items]
Settlement amount								$ 112,418	$ 86,811
Amended Employment Agreement [Member] | Stephen Morris [Member]
Other Commitments [Line Items]
Compensate salary						$ 450,000
Deferred compensation						$ 5,000,000
Deferred compensation										$ 270,000
Amended Employment Agreement [Member] | Chetwood [Member]
Other Commitments [Line Items]
Compensate salary						60%
Deferred compensation						$ 5,000,000
Deferred compensation						450,000
Deferred compensation payment						$ 180,000
Non-vested share options									1,092,000
Amended Employment Agreement [Member] | David Chetwood [Member]
Other Commitments [Line Items]
Deferred compensation										236,200
Amended Employment Agreement [Member] | David Chetwood [Member] | Maximum [Member]
Other Commitments [Line Items]
Annual payment										450,000
Amended Employment Agreement [Member] | David Chetwood [Member] | Minimum [Member]
Other Commitments [Line Items]
Annual payment										180,000
Amended Employment Agreement [Member] | Burks [Member]
Other Commitments [Line Items]
Share-Based compensation arrangement description		Company agreed to grant Mr. Burks an option to purchase 4,800,000 shares of common stock at $0.1353 per share ($649,440), with 40% vesting after 90 days of service and 60% vesting monthly over the following two years				Company entered into an employment agreement with Timothy Burks, Chief Executive Officer, and Director. The Company will compensate Mr. Burks $600,000 per annum base pay with payments reduced by 60% to $240,000 per annum until the Company has secured $5,000,000 in debt or equity financing.
Amended Employment Agreement [Member] | Mr.Burks [Member]
Other Commitments [Line Items]
Non-vested share options									1,800,000
Amended Employment Agreement [Member] | Timothy Burks [Member]
Other Commitments [Line Items]
Deferred compensation										270,000
Amended Employment Agreement [Member] | Timothy Burks [Member] | Maximum [Member]
Other Commitments [Line Items]
Annual payment										600,000
Amended Employment Agreement [Member] | Timothy Burks [Member] | Minimum [Member]
Other Commitments [Line Items]
Annual payment										240,000
Non Executive Director Agreement [Member] | Paul Morrissey [Member]
Other Commitments [Line Items]
Share-Based compensation arrangement description					Company entered into a Non-executive Director Agreement with Paul Morrissey. The Company will compensate Mr. Morrissey $300,000 per annum directors fee, with payments reduced by 60% to $120,000 per annum until the Company has secured $5,000,000 in debt or equity financing.
Non Executive Director Agreement [Member] | Mr Morrissey [Member]
Other Commitments [Line Items]
Share-Based compensation arrangement description	Company agreed to grant Mr. Morrissey an option to purchase 1,920,000 shares of common stock at $0.1353 per share ($259,776), with 40% vesting after 90 days of service and 60% vesting monthly over the following two years
Non-vested share options									720,000
Non Executive Director Agreement [Member] | Morrissey [Member]
Other Commitments [Line Items]
Deferred compensation										270,000
Non Executive Director Agreement [Member] | Morrissey [Member] | Maximum [Member]
Other Commitments [Line Items]
Annual payment										300,000
Non Executive Director Agreement [Member] | Morrissey [Member] | Minimum [Member]
Other Commitments [Line Items]
Annual payment										$ 120,000
Virtual Office Space [Member]
Other Commitments [Line Items]
Monthly rate									$ 200